Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Corrigendum to "Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis" [Int. Immunopharmacol. 57 (2018) 112-120].

Kos O, Alexander C, Brandenburg K, Chen Z, Heini A, Heumann D, Khatri I, Mach JP, Rietschel ET, Terskikh A, Ulmer AJ, Waelli T, Yu K, Zähringer U, Gorczynski RM.

Int Immunopharmacol. 2018 Jun;59:413. doi: 10.1016/j.intimp.2018.04.024. Epub 2018 Apr 19. No abstract available.

PMID:
29681496
2.

Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis.

Kos O, Alexander C, Brandenburg K, Chen Z, Heini A, Heumann D, Khatri I, Mach JP, Rietschel ET, Terskikh A, Ulmer AJ, Waelli T, Yu K, Zähringer U, Gorczynski RM.

Int Immunopharmacol. 2018 Apr;57:112-120. doi: 10.1016/j.intimp.2018.02.010. Epub 2018 Feb 23. Erratum in: Int Immunopharmacol. 2018 Apr 19;:.

PMID:
29477972
3.

Analysis of cytokine immune response profile in response to inflammatory stimuli in mice with genetic defects in fetal and adult hemoglobin chain expression.

Khatri I, Alexander C, Brandenburg K, Chen Z, Heini A, Heumann D, Mach JP, Mazzoli V, Rietschel E, Terskikh A, Ulmer A, Yu K, Zähringer U, Gorczynski R.

Pharmacogenomics J. 2018 Jul;18(4):546-555. doi: 10.1038/s41397-017-0008-y. Epub 2018 Jan 4.

PMID:
29302041
4.

My mother and me.

Heumann D.

Top Stroke Rehabil. 2007 May-Jun;14(3):95-6. No abstract available.

PMID:
17573315
5.

Monocyte deactivation in septic shock.

Heumann D, Glauser MP, Calandra T.

Curr Opin Infect Dis. 1998 Jun;11(3):279-83.

PMID:
17033392
6.

Polarized XANES spectra of titanium dichalcogenides - experiment and theory.

Sipr O, Simůnek A, Bocharov S, Heumann D, Dräger G.

J Synchrotron Radiat. 1999 May 1;6(Pt 3):518-20. Epub 1999 May 1. No abstract available.

PMID:
15263365
7.

The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds.

Heumann D, Lauener R, Ryffel B.

J Endotoxin Res. 2003;9(6):381-4. Review.

PMID:
14733725
8.

Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice.

Lanza-Jacoby S, Miller S, Jacob S, Heumann D, Minchenko AG, Flynn JT.

J Endotoxin Res. 2003;9(6):341-7.

PMID:
14733720
10.

Cytokines in septic shock.

Calandra T, Bochud PY, Heumann D.

Curr Clin Top Infect Dis. 2002;22:1-23. Review. No abstract available.

PMID:
12520644
11.
12.

Initial responses to endotoxins and Gram-negative bacteria.

Heumann D, Roger T.

Clin Chim Acta. 2002 Sep;323(1-2):59-72. Review.

PMID:
12135807
13.

The role of lipopolysaccharide binding protein in resistance to Salmonella infections in mice.

Fierer J, Swancutt MA, Heumann D, Golenbock D.

J Immunol. 2002 Jun 15;168(12):6396-403.

14.

CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria.

Heumann D.

J Endotoxin Res. 2001;7(6):439-41. Review.

PMID:
11753213
15.

Cathelicidin family of antibacterial peptides CAP18 and CAP11 inhibit the expression of TNF-alpha by blocking the binding of LPS to CD14(+) cells.

Nagaoka I, Hirota S, Niyonsaba F, Hirata M, Adachi Y, Tamura H, Heumann D.

J Immunol. 2001 Sep 15;167(6):3329-38.

16.

Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria.

Le Roy D, Di Padova F, Adachi Y, Glauser MP, Calandra T, Heumann D.

J Immunol. 2001 Sep 1;167(5):2759-65.

17.

CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia.

de Werra I, Zanetti G, Jaccard C, Chioléro R, Schaller MD, Yersin B, Glauser MP, Calandra T, Heumann D.

Swiss Med Wkly. 2001 Jan 27;131(3-4):35-40.

18.

Role of plasma, lipopolysaccharide-binding protein, and CD14 in response of mouse peritoneal exudate macrophages to endotoxin.

Heumann D, Adachi Y, Le Roy D, Ohno N, Yadomae T, Glauser MP, Calandra T.

Infect Immun. 2001 Jan;69(1):378-85.

19.

Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness.

Piani A, Hossle JP, Birchler T, Siegrist CA, Heumann D, Davies G, Loeliger S, Seger R, Lauener RP.

Eur J Immunol. 2000 Nov;30(11):3140-6.

20.

Production of the acute-phase protein lipopolysaccharide-binding protein by respiratory type II epithelial cells: implications for local defense to bacterial endotoxins.

Dentener MA, Vreugdenhil AC, Hoet PH, Vernooy JH, Nieman FH, Heumann D, Janssen YM, Buurman WA, Wouters EF.

Am J Respir Cell Mol Biol. 2000 Aug;23(2):146-53.

PMID:
10919979
21.

Protection from septic shock by neutralization of macrophage migration inhibitory factor.

Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hültner L, Heumann D, Männel D, Bucala R, Glauser MP.

Nat Med. 2000 Feb;6(2):164-70.

PMID:
10655104
22.

Purification of lipopolysaccharide binding protein.

Heumann D.

Methods Mol Med. 2000;36:45-56. doi: 10.1385/1-59259-216-3:45.

PMID:
21340963
23.

Genomic organization and chromosomal localization of the mouse lipopolysaccharide binding protein gene.

Lengacher S, Reed D, Heumann D, Jongeneel CV.

Immunogenetics. 1999 Jun;49(6):553-6. No abstract available.

PMID:
10380702
24.
25.

Digestion of Streptococcus pneumoniae cell walls with its major peptidoglycan hydrolase releases branched stem peptides carrying proinflammatory activity.

Majcherczyk PA, Langen H, Heumann D, Fountoulakis M, Glauser MP, Moreillon P.

J Biol Chem. 1999 Apr 30;274(18):12537-43.

26.

Molecular basis of host-pathogen interaction in septic shock.

Heumann D, Glauser MP, Calandra T.

Curr Opin Microbiol. 1998 Feb;1(1):49-55. Review.

PMID:
10066457
27.

Nitric oxide production in experimental gram-negative infection: studies with cytokine receptor-deficient mice.

Le Roy D, Heumann D, Glauser MP, Mauël J, Smith J, Betz Corradin S.

Shock. 1998 Jul;10(1):37-42.

PMID:
9688089
28.

The pathogenic role of LBP in gram-negative sepsis and septic shock.

Heumann D, Lengacher S, Le Roy D, Jongeneel CV, Glauser MP.

Prog Clin Biol Res. 1998;397:379-86. Review. No abstract available.

PMID:
9575578
29.

Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia.

de Werra I, Jaccard C, Corradin SB, Chioléro R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner JD, Glauser MP, Heumann D.

Crit Care Med. 1997 Apr;25(4):607-13.

PMID:
9142024
30.

Similarities and disparities between core-specific and O-side-chain-specific antilipopolysaccharide monoclonal antibodies in models of endotoxemia and bacteremia in mice.

Bailat S, Heumann D, Le Roy D, Baumgartner JD, Rietschel ET, Glauser MP, Di Padova F.

Infect Immun. 1997 Feb;65(2):811-4.

31.

Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway.

Le Roy D, Morand P, Lengacher S, Celio M, Grau GE, Glauser MP, Heumann D.

Infect Immun. 1996 May;64(5):1846-9.

32.

Anticytokine strategies for the treatment of septic shock: relevance of animal models.

Heumann D, Glauser MP.

Curr Top Microbiol Immunol. 1996;216:299-311. Review. No abstract available.

PMID:
8791746
33.

Do monoclonal antibodies and anticytokines still have a future in infectious diseases?

Cohen J, Heumann D, Glauser MP.

Am J Med. 1995 Dec 29;99(6A):45S-52S; discussion 52S-53S. Review.

PMID:
8585536
34.

Characterisation of bovine lipopolysaccharide binding protein and the in vivo acute phase response to Pasteurella haemolytica Type A.

Horadagoda NU, Eckersall PD, Andrew L, Gallay P, Heumann D, Gibbs HA.

Vet Immunol Immunopathol. 1995 Nov;49(1-2):61-74.

PMID:
8588345
35.

Lipopolysaccharide binding protein as a marker of inflammation in synovial fluid of patients with arthritis: correlation with interleukin 6 and C-reactive protein.

Heumann D, Bas S, Gallay P, Le Roy D, Barras C, Mensi N, Glauser MP, Vischer T.

J Rheumatol. 1995 Jul;22(7):1224-9.

PMID:
7562749
36.

Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis.

Heumann D, Le Roy D, Zanetti G, Eugster HP, Ryffel B, Hahne M, Tschopp J, Glauser MP.

J Inflamm. 1995-1996;47(4):173-9.

PMID:
9144074
37.

Reactivity of murine and human recombinant LPS-binding protein (LBP) within LPS and gram negative bacteria.

Lengacher S, Jongeneel CV, Le Roy D, Lee JD, Kravchenko V, Ulevitch RJ, Glauser MP, Heumann D.

J Inflamm. 1995-1996;47(4):165-72.

PMID:
9144073
38.

Contribution of lipopolysaccharide binding protein (LBP) in endotoxemic shock in mice.

Heumann D, Gallay P, Le Roy D, Glauser MP.

Prog Clin Biol Res. 1995;392:465-71. No abstract available.

PMID:
8524953
39.

Lipopolysaccharide (LPS)-binding protein in human serum determines the tumor necrosis factor response of monocytes to LPS.

Gallay P, Barras C, Tobias PS, Calandra T, Glauser MP, Heumann D.

J Infect Dis. 1994 Nov;170(5):1319-22.

PMID:
7963737
40.

Mode of action of anti-lipopolysaccharide-binding protein antibodies for prevention of endotoxemic shock in mice.

Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP.

Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7922-6.

41.

Spin-dependent generalized collective model in relation to the j=3/2 interacting boson fermion model.

Heumann D, Greiner M, Scheid W, Braunss G.

Phys Rev C Nucl Phys. 1994 Aug;50(2):812-817. No abstract available.

PMID:
9969723
42.

Identification of lipopolysaccharide binding protein-like activity in bovine serum.

Horadagoda NU, Eckersall PD, Andrew L, Gallay P, Heumann D, Gibbs HA.

Biochem Soc Trans. 1994 Aug;22(3):329S. No abstract available.

PMID:
7529725
43.

Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes.

Heumann D, Barras C, Severin A, Glauser MP, Tomasz A.

Infect Immun. 1994 Jul;62(7):2715-21.

44.

Radioimmunoassay versus flow cytometric assay to quantify LPS-binding protein (LBP) concentrations in human plasma.

Heumann D, Gallay P, Le Roy D, Landmann R, Glauser MP.

J Immunol Methods. 1994 May 16;171(2):169-76.

PMID:
7515085
45.

Interferon gamma receptor deficient mice are resistant to endotoxic shock.

Car BD, Eng VM, Schnyder B, Ozmen L, Huang S, Gallay P, Heumann D, Aguet M, Ryffel B.

J Exp Med. 1994 May 1;179(5):1437-44.

46.

Pathogenesis and potential strategies for prevention and treatment of septic shock: an update.

Glauser MP, Heumann D, Baumgartner JD, Cohen J.

Clin Infect Dis. 1994 Feb;18 Suppl 2:S205-16. Review.

PMID:
8148464
47.

Bactericidal/permeability-increasing protein inhibits induction of macrophage nitric oxide production by lipopolysaccharide.

Corradin SB, Heumann D, Gallay P, Smith J, Mauël J, Glauser MP.

J Infect Dis. 1994 Jan;169(1):105-11.

PMID:
8277172
48.

Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock.

Gallay P, Heumann D, Le Roy D, Barras C, Glauser MP.

Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9935-8.

49.

IFN-gamma involvement in the severity of gram-negative infections in mice.

Kohler J, Heumann D, Garotta G, LeRoy D, Bailat S, Barras C, Baumgartner JD, Glauser MP.

J Immunol. 1993 Jul 15;151(2):916-21.

PMID:
8335919
50.

Competition between bactericidal/permeability-increasing protein and lipopolysaccharide-binding protein for lipopolysaccharide binding to monocytes.

Heumann D, Gallay P, Betz-Corradin S, Barras C, Baumgartner JD, Glauser MP.

J Infect Dis. 1993 Jun;167(6):1351-7.

PMID:
8501324

Supplemental Content

Loading ...
Support Center